Product Images Ramipril

The text describes a chart that compares the proportion of patients in a medical study over a certain number of days of follow-up. The study involves a placebo and a drug called Ramipril. The chart displays the data for patients over 20 years of age. The proportion of patients who took Ramipril decreased over the follow-up period, and the proportion of patients who took the placebo increased. The chart indicates that the use of Ramipril has a statistically significant effect on patient outcomes.*

This text provides a table showing the incidence of a composite outcome in different patient groups. It includes the number of patients in the placebo group and provides information such as cardiovascular disease, diabetes, age groups, sex, hypertension, coronary artery disease, prior myocardial infarction, cerebrovascular disease, peripheral vascular disease, and microalbuminuria. The relative risk in the Ramipril group is also included with a confidence interval.*

This is a medication package for Ramipril 5mg capsules manufactured by Lupin. It is advised to be stored at room temperature and kept out of the reach of children. The package contains 30 capsules and has an expiration date of MM/YY. The NDC number is 7133596451 01254301523487. The first line of text seems unrelated to the medication and might include a location or an entity name.*